News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Runhao Li

Articles by Runhao Li

4 Bacopaside: Exploring Its Potential in Addressing Chemoresistance and Modulating Doxorubicin Accumulation in Triple-Negative Breast Cancer Cells

4 Bacopaside: Exploring Its Potential in Addressing Chemoresistance and Modulating Doxorubicin Accumulation in Triple-Negative Breast Cancer Cells

BySima K. Rad,Kenny K. L. Yeo,Runhao Li,Saifei Liu,Fangmeinuo Wu,Kevin A. Fenix,Timothy J. Price,Wendy Ingman,Amanda R. Townsend,Eric Smith

August 29th 2024

Latest Updated Articles

Trending on CancerNetwork

Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group

What is the Impact of the SHARON Trial on Pancreatic Cancer Research?

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC

Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy

Career Stage and Location Found to Impact Oncology Coverage in the US

© 2025 MJH Life Sciences^®

All rights reserved.